DNA-Guided heart drug shows promise in preventing clots and death

NCT ID NCT06665919

First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 19 times

Summary

This study looked at whether using a person's genetic information to choose their blood thinner (clopidogrel or an alternative) leads to better outcomes after a heart procedure. About 283 adults with chronic coronary artery disease who had a stent placed were split into two groups: one got the standard blood thinner, and the other had their DNA tested to pick the best option. The goal was to see if the genetic approach could reduce deaths, heart attacks, and other serious heart events.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • 1st University Clinic of the Tbilisi State Medical University

    Tbilisi, Georgia

  • Cardio Expert Ltd., Clinic Cardio

    Tbilisi, Georgia

  • T. Oragvelidze Cardiology Center

    Tbilisi, Georgia

  • Tbilisi Institute of Medicine

    Tbilisi, Georgia

Conditions

Explore the condition pages connected to this study.